delia goletti retweeted
Yet another fantastic #CTVD meeting!
@gatesfoundation
Interesting presentation by Chiara Farroni at #ESCMIDGlobal on immune memory response to #Mycobacterium #tuberculosis in #IMID patients from #Translational Research unit #INMI #spallanzani #IRCCS
95
Interesting presentation by Elisa Petruccioli at #ESCMIDGlobal on immune memory response to MPXV from #Translational Research unit #INMI #spallanzani #IRCCS
2
90
Wonderful #ESCMIDGlobal meeting in #Barcelona! Great opportunity to present my work, outstanding lectures, possibility for #INMI #IRCCS #Spallanzani for new interactions!
2
5
140
delia goletti retweeted
We're pleased to contribute & share this new research on latent tuberculosis (LTBI) screening in migrants for #WorldTBDay! ➡️ ijidonline.com/article/S1201…
Take-home messages:
Diagnosing LTBI in migrants is complex
Screening & preventive treatment are key
More research needed on effective screening programs
#PublicHealth #Tuberculosis #IJID @ISID
It is important to invest in Research against #TB. In a special issue of the International Journal of Infectious Diseases, published by @ISID, some new aspects on the fight against TB are reprted. ➡️ ijidonline.com/article/S1201…… #PublicHealth #Tuberculosis #IJID
Investing in #TB R&D is not just imperative to advancing the prevention, diagnosis, treatment, and care of #tuberculosis, it's also a smart investment in #globalhealth. Join partners around the world to raise awareness this #WorldTBDay: tballiance.org/world-tb-day-… #YesWeCanEndTB
3
206
delia goletti retweeted
Today is #WorldTBDay & we're saying #YesWeCanEndTB! 💪 This special issue of the International Journal of Infectious Diseases, published by @ISID, discusses the ongoing fight against TB. ➡️ ijidonline.com/article/S1201… #PublicHealth #Tuberculosis #IJID
delia goletti retweeted
While celebrating World TB Day 2024, we need to improve the the testing and the access to drugs in many European countries @StopTbItalia @FerrareseMauri1 @Nanni_Sotgiu @Deliagoletti2 @AlibertiStefano @edo_simonetta @RiccardiNiccolo @M_Raviglione @maura_spotti
Running late: lack of access to optimal MDR/RR-TB treatment and resistance testing in Europe
A new TBnet study has just been published
tbnet.eu/post/press-release-…
For the 2024 World TB Day, IJID prepared a special issue to highlight prectices and innovations in tuberculosis. sciencedirect.com/journal/in…
delia goletti retweeted
21 malattie sconosciute, senza ricerca, senza cure, senza vaccini. Legate a conflitti, povertà e cambi climatici, tutte sulle spalle della gente più povera tra i poveri. Ecco oggi è la festa delle malattie tropicali dimenticate. 30.01.24. @ntd @INMISpallanzani @WHO @ISSalute_it
Yes! We Can #EndTB!” is the #WHO and #STOP TB Partnership theme for #worldtbday 2023. In this special #IJID World TB Day issue we present 9 reports covering issues to consider to #End TB, as #vaccines, #MDR-TB management, preventive therapy, #COVID-19/TB doi.org/10.1016/j.ijid.2023.…
delia goletti retweeted
3* Seminario su TB e NTM a Villa Marelli. 20 partecipanti. Top Speakers. #EndTB #NTM @Nanni_Sotgiu @FerrareseMauri1 @AlibertiStefano @registro_irene @GiorgioPol @StopTbItalia @Deliagoletti2 @RiccardiNiccolo @BindoFrancesco @NicolaIvanLore
Honored to be part of the faculty of the #ESCMID Summer School and talk on challenges in #tuberculosis treatment. Very talented students from worldwide that bring curiosity, intelligence, freshness. And to defeat #tuberculosis and #endTB, we are all needed and called to action.
🫁 There are still challenges in tuberculosis treatment - an exciting presentation by @Deliagoletti2 @ESCMID Summer School
👉 we need to"reimagine"our
research response to TB and bring TB research into the 21st century
delia goletti retweeted
🔎 Led by Dr. @DeliaGoletti2, scientists at the National Institute for Infectious Diseases in Italy found that #cysteamine exerts in vitro antiviral activity against the #SARSCoV2 Delta and #Omicron variants.
@cddpress: go.nature.com/3ydXqh2
Wonderful experience to work with the #ECIL group on the #guidelines on #Mycobacterial infections in adults with haematological #malignancies and haematopoietic stem cell #transplants, now published on Lancet Infectious Diseases. authors.elsevier.com/c/1f8uZ…
delia goletti retweeted
Networks statement: Lack of access to rifapentine in Europe denies patients optimal care for active tuberculosis & latent tuberculosis infection @TBnet_EU @EuroRespSoc ESGMYC @ESCMID @FlorianPMaurer @gglond @FvLScience @RaquelAFDuarte @Deliagoletti2 @SimonTiberi @ChristophLange
#Rifapentine access in Europe: growing concerns over key #tuberculosis treatment component
by L Gulglielmeti et al
We need improved access to this drug around the world for better TB control!
@esgmyc #esm @TBnet_EU @ERSpublications @EuroRespSoc @ESCMID
erj.ersjournals.com/content/…
delia goletti retweeted
Replying to @Eurosurveillanc @sal_hargreaves @hayward_sally @StopTB @TeyNoori @Deliagoletti2 @DrCGreenaway
Screening for latent TB infection including migrants
🔸was reported for 15 countries
🔹was planned in the near future in 5 countries
🔸was not planned in 10 countries
#LTBI screening was predominantly for asylum seekers (n = 12) & refugees (n = 11)
https://nitter.cf/t.co/mssFzRnxCt

ALT The authors found a range of approaches to latent tuberculosis infections screening of migrants in the EU/EEA and Switzerland. Findings suggest a renewed focus is needed to expand and strengthen efforts to meaningfully include migrants in these programmes, in order to meet regional and global elimination targets for TB.
delia goletti retweeted
New Review: Immune-Guided Therapy of #COVID19 by Ferraccioli, Bronte et al.
https://nitter.cf/t.co/RB5z7fKIxS
@EGremese @Deliagoletti2 @StefanoUgel #CIRReviewerStar ⭐
La tubercolosi è una malattia prevenibile e curabile.
Tuttavia la mortalità nel 2020 è stata del 15%.
È importante fare azioni politiche, sanitarie, economiche congiunte per ridurre la diffusione e migliorare l'accesso alle cure.
This Post is from an account that no longer exists. Learn more
Onorata e grata di avere ricevuto questo premio "she made a difference 2021"dalla associazione #EWMD il 26 novembre al #Senato.
Honored and grateful to have received the award "she made a difference 2021" from (#EWMD) association on November 26 at the Senate.
“Ascoltare i #pazienti, perché sono i pazienti che hanno in sè tutte le domande scientifiche cui vale la pena rispondere.” E' questa la mission della premiata ricercatrice Prof.ssa @Deliagoletti2
@EUPATI_IT @eupatientsforum
carolapulvirenti.it/premiata…
7





























